Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tianjin Conjustar Biologics Co., Ltd.

Clinical trials sponsored by Tianjin Conjustar Biologics Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug targets Gene-Amplified breast cancers in early trial Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New drug targets Gene-Amplified breast cancers in early trial

Disease control Not yet recruiting

This study tests a new drug called SC-101 in 120 people with advanced breast cancer (triple-negative or hormone-receptor-positive) that has a specific gene change called NECTIN4 amplification. Participants receive the drug once a week through an IV. The goal is to see if the drug…

Phase 2 • Sponsor: Tianjin ConjuStar Biologics Co., Ltd. • Aim: Disease control

Last updated Jun 26, 2026 16:32 UTC